APA (7th ed.) Citation

Zhuravleva, M. V., Tereshchenko, S. N., Zhirov, I. V., Nedogoda, S. V., Gagarina, Y. V., & Shabalina, E. A. Сost-effectiveness of preventing cardiovascular death and achieving the target indicator "Reduction of the cardiovascular mortality of the population" of the State Program "Health Development" when using valsartan+sacubitril, dapagliflozin and empagliflozin in patients with heart failure with reduced ejection fraction. «FIRMA «SILICEA» LLC.

Chicago Style (17th ed.) Citation

Zhuravleva, M. V., S. N. Tereshchenko, I. V. Zhirov, S. V. Nedogoda, Yu. V. Gagarina, and E. A. Shabalina. Сost-effectiveness of Preventing Cardiovascular Death and Achieving the Target Indicator "Reduction of the Cardiovascular Mortality of the Population" of the State Program "Health Development" When Using Valsartan+sacubitril, Dapagliflozin and Empagliflozin in Patients with Heart Failure with Reduced Ejection Fraction. «FIRMA «SILICEA» LLC.

MLA (9th ed.) Citation

Zhuravleva, M. V., et al. Сost-effectiveness of Preventing Cardiovascular Death and Achieving the Target Indicator "Reduction of the Cardiovascular Mortality of the Population" of the State Program "Health Development" When Using Valsartan+sacubitril, Dapagliflozin and Empagliflozin in Patients with Heart Failure with Reduced Ejection Fraction. «FIRMA «SILICEA» LLC.